INTESTINAL ULTRASOUND RESPONSE AND TRANSMURAL REMISSION AFTER 48 WEEKS OF TREATMENT WITH USTEKINUMAB IN CROHN’S DISEASE: STARDUST TRIAL SUBSTUDY RESULTS BY LINE OF TREATMENT AND LOCATION

Rune Wilkens  ¹     Maria-Antonietta D'Agostino  ²     Giovanni Maconi  ³     Manuela Le Bars  ⁴     Marjolein Lahaye  ⁵     Ivana Bravata  ⁶     Lioudmila Ni     Elena Ercole     Mariangela Allocca     Nadezda Machkova     Floris A E de Voogd     Carolina Palmela     Rose Vaughan     Christian Maaser     Torsten Kucharzik     Maciej Nazar    
¹ Hvidovre Hospital,Copenhagen,Denmark
² Fondazione Policlinico Universitario Agostino Gemelli IRCSS, Università Cattolica del Sacro Cuore,Rome,Italy
³ "Luigi Sacco" University Hospital, University of Milan,Milan,Italy
⁴ Janssen-Cilag SARL,Issy-les-Moulineaux,France
⁵ Janssen-Cilag B.V.,Breda,Netherlands
⁶ Janssen-Cilag S.p.A.,Milan,Italy

Session
IBD (Posters)

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 1)